交易中 10-08 11:05:09 美东时间
-0.060
-0.09%
Bannerman Energy ( ($AU:BMN) ) has issued an announcement. Bannerman Energy has...
10-06 13:28
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从49美元升至50美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从24美元升至25美元
10-02 08:33
Piper Sandler analyst Matthew Clark maintains Banner (NASDAQ:BANR) with a Neutral and lowers the price target from $74 to $71.
10-01 21:22
NYU Langone Health has joined Aclarion's CLARITY trial to evaluate Nociscan, a technology using MR Spectroscopy and AI to identify sources of chronic low back pain. The trial aims to demonstrate Nociscan's ability to improve surgical outcomes. NYU Langone, a leading spine care center, will contribute to the multi-center study, which includes 300 patients undergoing spine surgery. Nociscan has shown a 97% surgical success rate when all pain-causin...
09-29 11:00
An announcement from Bannerman Energy ( ($AU:BMN) ) is now available. Bannerman...
09-29 07:03
Bannerman Energy ( ($AU:BMN) ) has shared an announcement. Bannerman Energy has...
09-09 07:58
We all knew that the merger between entertainment giant Paramount Skydance ($PS...
09-05 03:38
Humacyte's Symvess, the first FDA-approved bioengineered human blood vessel, is now being used in Arizona by Dr. Jeromy Brink, a vascular surgeon at Banner University Medical Center in Phoenix. Symvess is an off-the-shelf solution for urgent revascularization in adults with extremity arterial injury, eliminating the need to harvest veins from patients. Dr. Brink, who has performed four implants since gaining access two weeks ago, calls Symvess th...
08-18 12:00
Bannerman Energy ( ($AU:BMN) ) has issued an update. Bannerman Energy has relea...
08-17 09:17